Didn't turn out that way, now did it? Cant wait for

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks SaltyMutt #122142
376
Didn't turn out that way, now did it?

Cant wait for Sarah Cooper to get her hands on excerpts of Trump's comments with her as Harris reaction shots. Be hard to beat the actual reaction shots shown below. 'How to Crash and Burn' would be a good title.

In Debate With Trump, Harris’s Expressions Were a Weapon

Tuesday’s debate was expected to center on defining Kamala Harris. Instead, with words and with body language, she turned it into a referendum on Donald Trump.




By Lisa Lerer and Reid J. Epstein
Lisa Lerer reported from New York and Reid J. Epstein reported from the debate in Philadelphia.

Sept. 11, 2024
Updated 3:59 a.m. ET

https://www.nytimes.com/2024/09/11/us/politic...lysis.html

She turned to him with an arched brow. A quiet sigh. A hand on her chin. A laugh. A pitiful glance. A dismissive shake of her head.

From the opening moments of her first debate against Donald J. Trump, Kamala Harris craftily exploited her opponent’s biggest weakness.

Not his record. Not his divisive policies. Not his history of inflammatory statements.

Instead, she took aim at a far more primal part of him: his ego.

At his rallies, on his sycophantic social media network and surrounded by flatterers at Mar-a-Lago, Mr. Trump is unquestioned, unchallenged and never ever mocked.


That changed over the course of 90 minutes in Philadelphia on Tuesday, when the woman who had never before met him succeeded, bit by bit, in puncturing his comfortable cocoon and triggering his annoyance and anger.

Ms. Harris questioned the size and loyalty of the crowds at his rallies. She said world leaders call him a “disgrace.” And she claimed his fortune was built by his father, recasting a business mogul who proudly boasts of being a self-made man as just another nepotism baby.

Then she stood by and watched, as Mr. Trump did himself a whole lot of damage.

In answer after answer, the former president reminded Americans of his role in so much of what many would rather forget: the deadly and devastating pandemic, his refusal to accept the results of the 2020 election, a bloody siege on the U.S. Capitol and the fall of Roe v. Wade. He lingered on his criminal charges and praised Viktor Orban, the strongman leader of Hungary. He defended a false claim that migrants in Ohio are eating their neighbors’ dogs and cats and recycled years-old anti-abortion attack lines that Democrats supported “execution after birth.”

In such a fractured and polarized country, it remains unclear how the lopsided debate may alter the 2024 presidential race. But the immediate reaction was telling: Mr. Trump led Republicans in attacking the moderators — the debate was “three-on-one,” he complained — while Democrats notched perhaps the most important endorsement of the election cycle with Taylor Swift.

“He is so easy to trigger,” Gov. Gavin Newsom of California, a Harris ally, said in the post-debate spin room.

Since her head-spinning ascension to the Democratic ticket in July, Ms. Harris has faced a race focused on her record, history and shifts in positions. But from the moment she crossed the stage to shake Mr. Trump’s hand, the Democratic presidential nominee made clear her intention to transform a night expected to be about her into a referendum on him.

She displayed a composure and tactical restraint that was palpable through the television screen. Equally palpable was his fury, which at times seemed to make him unable to even look at his opponent.

“She’s a Marxist — everybody knows she’s a Marxist,” Mr. Trump said when Ms. Harris accused him of coddling China during the coronavirus pandemic. “Her father is a Marxist professor in economics, and he taught her well.”

Ms. Harris looked at him with a condescending smile, performatively leaning in to hear more. He’s the former reality television star, but she clearly understood the power of the medium. Her expression was her rebuttal. And when her turn to speak came, she focused not on rebutting the attacks on her character and ideology, but on the far more politically potent issue of abortion rights.

Mr. Trump, she charged, would ban abortion nationwide and monitor women’s pregnancies to ensure they carried the baby to term. Already, current restrictions in some states, she told viewers, make no exceptions for victims of rape or incest.

“That is immoral and one does not have to abandon their faith or deeply held beliefs to agree the government and Donald Trump certainly should not be telling a woman what to do with her body,” she said.

Instead of attacking Mr. Trump as an existential threat to democracy, as President Biden so often did, Ms. Harris invited voters to judge the former president for themselves. She urged them to attend one of his campaign events, hear his references to “fictional characters like Hannibal Lecter” and his claims that “windmills cause cancer,” and watch his followers leave early.

“The one thing you will not hear him talk about is you,” she said into the camera. “You will not hear him talk about your needs, your dreams and your desires, and I’ll tell you, I believe you deserve a president who actually puts you first, and I pledge to you that I will.”

Mr. Trump quickly responded, but not to dispute her criticism that he was not tuned into voters’ needs. Instead, he defended his crowds.

“People don’t leave my rallies,” Mr. Trump said. “We have the biggest rallies, the most incredible rallies in the history of politics.”

By the end of the debate, Ms. Harris turned one of the worst moments of the Biden presidency — the United States’ withdrawal from Afghanistan — into an attack on Mr. Trump, saying he “negotiated one of the weakest deals you can imagine” with the Taliban and invited its leaders to Camp David.

Even Mr. Trump’s allies grudgingly admitted the Harris strategy of trying to knock Mr. Trump off-balance was effective.


“She spent 90 minutes attacking Donald Trump, trying to get under his skin, to do everything to get away from her record as vice president of the United States,” Representative Byron Donalds of Florida said. “He defended himself like any human being would.”

In recent weeks, as the burst of enthusiasm around Ms. Harris’s candidacy has tempered, the questions about her policy positions and plans have grown. Very few were answered Tuesday night.

Aside from immigration, Mr. Trump did not effectively attack her over high costs of living. His attempts to paint her as a flip-flopper on energy policy and other key issues, and as too liberal for voters in swing states, largely failed to gain traction amid his focus on re-litigating old grievances.

Instead, Ms. Harris used the opportunity to explicitly appeal to the moderate voters and anti-Trump Republicans who helped deliver the White House to Mr. Biden in 2020. It’s a group Ms. Harris has struggled to win by the same margin and one that could, once again, play a decisive role in November.

As the governors, senators, activists and political gadflies spun his performance in the post-debate spin room, a surprise guest suddenly appeared and was swarmed by more than 100 journalists.

It was Donald Trump. Presidential candidates rarely — if ever — spin their own performances in the minutes after exiting the stage. But Mr. Trump couldn’t let it go.

“It was,” he said, “my best debate ever.”


Lisa Lerer is a national political reporter for The Times, based in New York. She has
1
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmunoGenesis Showcases STING Agonist Progress at SITC

Updated Category News Views 113

STING Agonists: The Next Frontier in Glioblastoma Treatment? Out there in the weeds of immunotherapy, ImmunoGenesis is gearing up for its moment at the SITC 2026 Annual Meeting with its STING agonist, IMGS-203. The stakes are skyscraper-high as this novel treatment makes a play against recurrent glioblastoma (GBM)—one tough cookie in the realm of brain cancers....

Continue Reading
PeptideWorld Paves the Way for Innovative Peptide Education

Updated Category News Views 27

The Rise of Peptide Education Imagine you're wading through a bog of health trends. That's how it feels trying to get a grip on peptide therapies these days, right? Luckily, PeptideWorld, powered by e?vita Health, is here to toss you a lifeline. They're transforming the landscape with a mission to ditch the marketing mumbo-jumbo for hard science. Their pitch?...

Continue Reading
FIS Slashes Forecast: Guidance Under Scrutiny Now

Updated Category News Views 28

Rough Waves for FIS Shareholders If there’s one thing I've learned chewing on greasy bacon over the years, it's that nothing rattles a stock like sketchy numbers and shattered investor confidence. Fidelity National Information Services, or FIS, has just yanked the rug out from its own 2026 forecast, cutting adjusted earnings per share (EPS) to a range of $5.82 to $5.89....

Continue Reading
Basildon Build-to-Rent Marks Progress for Starlight

Updated Category News Views 81

Basildon's New Housing Beacon Nears Completion No two construction milestones are the same, and Starlight Investments sure knows how to make theirs count. Reaching the skies with their project 'The Mercantile' in Basildon, the company has announced topping out—a significant phase in their build-to-rent development saga. With the structural peak reached, we're talking...

Continue Reading
Bluevua Triumphs with Three BASA Awards Wins

Updated Category News Views 18

Bluevua Sweeps the 2026 BASA Awards Stacking accolades like old trading wins, Bluevua just clinched not one, not two, but three 2026 Best of America Small Business Awards (BASA Awards®). If that's not a feather in their cap, I don't know what is. For the uninitiated, these BASA nods are no small potatoes—they're like the Oscars for small businesses. Bluevua, known for...

Continue Reading
Satisfi Labs Secures Two AI Patents, Boosts Reach

Updated Category News Views 78

Paving the Future with Patents Ah, patents. Like stock dividends for the tech world—they don’t change everything outright but can signal some mighty good things ahead. This time around, it’s Satisfi Labs who are in the spotlight. They’ve bagged not one, but two shiny U.S. patents to bolster what they’re calling Satisfi Forward. Honestly, it sounds like a...

Continue Reading
Omnicom Media: A Titan in Media Management Unveiled

Updated Category News Views 156

Omnicom Media's Latest Triumph Omnicom Media (NYSE: OMC) just snagged the 'Leader' badge in the ruthless world of media management services, according to Forrester's new report. Picture a chess game where every move counts—Omnicom's been playing for years, and they're a grandmaster at this point. This isn't some pat on the back; it's recognition of a powerhouse...

Continue Reading
Young Storytellers Honored: Bridging Cultures Through Journalism

Updated Category News Views 11

Leaders of Tomorrow: Campus News Awards 2026 It's no small feat to look at a room full of young journalists and see the future of how stories will be told. But that's exactly what happened at the Campus News Awards 2026 in Shenzhen. Here, kids from Hong Kong, Macao, Taiwan, and Southeast Asia stood proudly with their certificates, ready to tackle the changing landscape of...

Continue Reading
New Story Appoints Drudge, Celebrates Workplace Recognition

Updated Category News Views 103

A Dual Milestone: Leadership and Recognition In an industry chock-full of buzzwords, New Story’s latest moves cut through the noise. They've just announced Adam Drudge as their new Chief People Officer, and wouldn't you know it, they've snagged their third straight Most Loved Workplace® recognition for 2026. When a special ed company starts making waves like this,...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 125

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Arlo's New Floodlight Camera Enhances Security at Home and Beyond

Updated Category News Views 90

Introducing the Arlo Wired Floodlight Camera Arlo Technologies, Inc. (NYSE: ARLO), known for its leading smart home security solutions, has introduced an enhanced Wired Floodlight Camera. This innovative all-in-one DIY security solution builds on the company's successful line of wire-free floodlights, leveraging advanced technology to ensure that your outdoor spaces are...

Continue Reading
Bruce Berkowitz Sells Stake in St. Joe: Insights and Impacts

Updated Category News Views 121

Bruce Berkowitz's Significant Sell-Off of St. Joe Shares Recently, it was reported that BRUCE BERKOWITZ, a notable stakeholder of St. Joe (NYSE: JOE), executed a significant sell-off of his shares. According to a filing with the SEC, Berkowitz sold 71,900 shares at a total value of approximately $4.48 million. Such actions from insiders often draw the attention of...

Continue Reading
Yaamava' Resort & Casino Triumphs Again with Top Awards

Updated Category News Views 268

Yaamava' Resort & Casino Continues to Impress Critics and Guests Year after year, Yaamava' Resort & Casino at San Manuel has made a remarkable mark in the gaming industry, consistently rising to the top of prestigious rankings. Most recently, the resort secured its status once again by being voted the Best Overall Casino Outside of Las Vegas and Best Native American...

Continue Reading
Maro Achieves $4.3 Million Seed Funding for Cybersecurity Innovation

Updated Category News Views 516

Maro Secures Significant Seed Funding to Combat Cybersecurity Risks Maro, an innovative player in cognitive security, has successfully raised $4.3 million from Downing Capital Group. This funding is set to empower companies to better manage human risks associated with cybersecurity, transforming the way organizations deal with elements such as social engineering, insider...

Continue Reading
Transforming Cancer Care: The Rise of B7-H3 Inhibitors

Updated Category News Views 246

Understanding B7-H3 Inhibitors and Their Impact on Cancer Treatment The B7-H3 inhibitors market is rapidly emerging as a transformative force in oncology. The significant increase in investment from pharmaceutical giants alongside a rising number of cancer diagnoses has heightened interest and research in this area. This class of inhibitors aims to target the B7-H3...

Continue Reading